US FDA issues Form 483 with 10 observations to Sun Pharma’s Halol unit

Listed pharmaceutical entity Sun Pharmaceutical Industries on Tuesday informed the exchanges that the US FDA has issued Form 483 with ten observations to the company’s Halol unit.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/siIVoxR
via IFTTT